NASDAQ$SIGA
SIGA Technologies, Inc · Q1 2022 earnings
Q1 2022 earnings · · Investor relations
Briefing
SIGA Technologies' financial performance was marked by the first sale of IV TPOXX to the U.S. government and a new contract in the Asia Pacific region.
SIGA Technologies reported a revenue increase for the three months ended March 31, 2022, driven by the first sale of intravenous TPOXX to the U.S. government and a new international contract. The company also declared a special dividend of $0.45 per share.
- Total revenues increased to $10.5 million compared to $4.8 million in the same period last year.
- The first sale of intravenous (IV) TPOXX to the U.S. government was completed.
- A new contract was secured with a jurisdiction in the Asia Pacific region for approximately $3 million of oral TPOXX.
- The Board of Directors declared a special dividend of $0.45 per share.
Headline financials
Revenue & EPS history
SIGA Technologies · Revenue · Quarterly
$10.5M
Revenue by segment
SIGA Technologies · $10.5M total across 2 segments · Q1 2022
- Product Sales$7.32M+107.8%69.5%
- R&D Revenues$3.22M+149.4%30.5%
Forward guidance
SIGA Technologies did not provide specific forward guidance in this earnings report. The company's future performance is subject to various risks and uncertainties, including BARDA contract options, international market development, and the impact of COVID-19.
Tailwinds
- EMA approval broadens market access
- New contract with Asia Pacific jurisdiction
- Increased oral TPOXX procurement contract with Canada
- Research collaboration with Bioarchitech
- First sale of IV TPOXX to the U.S. government
Headwinds
- Risk that BARDA may not exercise all contract options
- Risk of not completing BARDA contracts on schedule
- Risk of BARDA contracts being modified or canceled
- Risk of international biodefense market not developing
- Risk of COVID-19 impacting SIGA's operations
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2022
-0.2%
Avg return
Earnings day
+0.5%
Avg return
5 days after
+2.4%
Avg return
30 days after
41%
26 / 64 earnings
Positive
+31.9%
Q4 2023
Best reaction
-27.8%
Q1 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.4% | -5.5% | -8.5% | |
| Q4 2025 | -3.0% | -3.4% | -22.8% | |
| Q3 2025 | -20.2% | -24.0% | -24.1% | |
| Q1 2025 | +4.4% | +9.0% | +10.8% | |
| Q4 2024 | +7.0% | +0.5% | +6.4% | |
| Q3 2024 | -1.9% | -8.5% | -9.8% | |
| Q2 2024 | -12.8% | -14.3% | -9.5% | |
| Q1 2024 | -27.8% | -28.2% | -26.7% | |
| Q4 2023 | +31.9% | +49.9% | +88.3% | |
| Q3 2023 | -4.4% | -2.2% | +16.9% | |
| Q2 2023 | -3.7% | -10.0% | -21.9% | |
| Q1 2023 | +5.1% | +1.8% | -0.7% | |
| Q4 2022 | -3.8% | -7.8% | -13.4% | |
| Q3 2022 | +7.5% | +9.8% | +1.1% | |
| Q2 2022 | +27.4% | +24.6% | -21.0% | |
| Q1 2022 | +3.6% | +4.0% | +60.7% | |
| Q4 2021 | +3.0% | +6.6% | +22.4% | |
| Q3 2021 | -0.7% | +0.0% | +2.8% | |
| Q2 2021 | -2.9% | -4.0% | +9.1% | |
| Q1 2021 | -0.7% | -8.4% | -10.4% | |
| Q4 2020 | +1.7% | +9.3% | +1.2% | |
| Q3 2020 | +2.0% | +3.4% | -0.9% | |
| Q2 2020 | +14.3% | +5.5% | -1.9% | |
| Q1 2020 | -1.4% | +1.4% | +2.9% | |
| Q4 2019 | +10.4% | +0.4% | +0.2% | |
| Q3 2019 | -3.2% | -1.8% | -19.8% | |
| Q2 2019 | +0.2% | -1.7% | +2.7% | |
| Q1 2019 | +1.5% | -1.3% | -12.8% | |
| Q4 2018 | -4.4% | -1.6% | -6.3% | |
| Q3 2018 | +8.4% | +5.7% | +29.1% | |
| Q2 2018 | +0.3% | +7.7% | +1.4% | |
| Q1 2018 | -0.5% | +2.4% | -3.9% | |
| Q4 2017 | -0.6% | -7.0% | -2.3% | |
| Q3 2017 | +2.8% | -1.1% | +3.9% | |
| Q2 2017 | -1.6% | -1.6% | -1.9% | |
| Q1 2017 | -0.3% | +0.6% | -8.0% | |
| Q4 2016 | -0.6% | +0.0% | -4.1% | |
| Q3 2016 | -5.7% | +3.8% | +54.8% | |
| Q2 2016 | +4.5% | +4.1% | +11.4% | |
| Q1 2016 | +1.1% | — | — | |
| Q4 2015 | +1.1% | — | — | |
| Q3 2015 | +2.4% | — | — | |
| Q2 2015 | -0.9% | — | — | |
| Q1 2015 | +5.7% | — | — | |
| Q4 2014 | -1.3% | — | — | |
| Q3 2014 | -0.7% | — | — | |
| Q2 2014 | -4.9% | — | — | |
| Q1 2014 | -1.4% | — | — | |
| Q4 2013 | -2.7% | — | — | |
| Q3 2013 | -3.5% | — | — | |
| Q2 2013 | -2.8% | — | — | |
| Q1 2011 | -2.4% | — | — | |
| Q4 2012 | -2.5% | — | — | |
| Q3 2012 | +6.5% | — | — | |
| Q2 2012 | +5.3% | — | — | |
| Q1 2012 | +4.5% | — | — | |
| Q4 2011 | -1.4% | — | — | |
| Q4 2009 | -1.4% | — | — | |
| Q3 2010 | -6.1% | — | — | |
| Q3 2011 | -6.1% | — | — | |
| Q2 2011 | -12.0% | — | — | |
| Q2 2010 | -12.0% | — | — | |
| Q4 2010 | -12.0% | — | — | |
| Q1 2010 | -1.4% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro